# Laureate Education, Inc.: financial statements, quarterly

LAUR · Nasdaq · CIK 912766 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/laur.md) · [Financials](/companies/laur/financials.md) · [Filings](/companies/laur/filings.md) · [Insiders](/companies/laur/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/laur/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [409 d](/filings/0001628280-26-009479.md) | [275](/filings/0001628280-25-021318.md) | [499](/filings/0001628280-25-036830.md) | [369](/filings/0001628280-25-047306.md) | [423 d](/filings/0001628280-26-009479.md) | [236](/filings/0001628280-26-028580.md) | [524](/filings/0001628280-26-050794.md) | [400](/filings/0000912766-26-000003.md) | [541 d](/filings/0001628280-26-009479.md) | [273](/filings/0001628280-26-028580.md) | [616](/filings/0001628280-26-050794.md) | [485](/filings/0000912766-26-000003.md) |
| Cost of revenue | $m | [279 d](/filings/0001628280-26-009479.md) | [254](/filings/0001628280-25-021318.md) | [319](/filings/0001628280-25-036830.md) | [286](/filings/0001628280-25-047306.md) | [288 d](/filings/0001628280-26-009479.md) | [238](/filings/0001628280-26-028580.md) | [317](/filings/0001628280-26-050794.md) | [317](/filings/0000912766-26-000003.md) | [348 d](/filings/0001628280-26-009479.md) | [289](/filings/0001628280-26-028580.md) | [378](/filings/0001628280-26-050794.md) | [353](/filings/0000912766-26-000003.md) |
| Operating income | $m | [110 d](/filings/0001628280-26-009479.md) | [11.1](/filings/0001628280-25-021318.md) | [167](/filings/0001628280-25-036830.md) | [72.0](/filings/0001628280-25-047306.md) | [124 d](/filings/0001628280-26-009479.md) | [(13.2)](/filings/0001628280-26-028580.md) | [193](/filings/0001628280-26-050794.md) | [71.5](/filings/0000912766-26-000003.md) | [179 d](/filings/0001628280-26-009479.md) | [(27.5)](/filings/0001628280-26-028580.md) | [223](/filings/0001628280-26-050794.md) | [119](/filings/0000912766-26-000003.md) |
| Interest expense | $m | [3.7 d](/filings/0001628280-24-006141.md) | [4.7](/filings/0001628280-24-019784.md) | [5.1](/filings/0001628280-25-036830.md) | [5.0](/filings/0001628280-25-047306.md) | [3.3 d](/filings/0001628280-26-009479.md) | [2.4](/filings/0001628280-26-028580.md) | [3.1](/filings/0001628280-26-050794.md) | [2.6](/filings/0000912766-26-000003.md) | [2.5 d](/filings/0001628280-26-009479.md) | [3.1](/filings/0001628280-26-028580.md) | [4.2](/filings/0001628280-26-050794.md) | [4.8](/filings/0000912766-26-000003.md) |
| Income tax | $m | [36.2 d](/filings/0001628280-26-009479.md) | [9.9](/filings/0001628280-25-021318.md) | [63.1](/filings/0001628280-25-036830.md) | [(0.5)](/filings/0001628280-25-047306.md) | [46.5 d](/filings/0001628280-26-009479.md) | [2.5](/filings/0001628280-26-028580.md) | [69.4](/filings/0001628280-26-050794.md) | [34.5](/filings/0000912766-26-000003.md) | [11.0 d](/filings/0001628280-26-009479.md) | [(5.7)](/filings/0001628280-26-028580.md) | [81.7](/filings/0001628280-26-050794.md) | [20.0](/filings/0000912766-26-000003.md) |
| Net income | $m | [41.9 d](/filings/0001628280-26-009479.md) | [(10.8)](/filings/0001628280-25-021318.md) | [128](/filings/0001628280-25-036830.md) | [85.5](/filings/0001628280-25-047306.md) | [93.6 d](/filings/0001628280-26-009479.md) | [(19.5)](/filings/0001628280-26-028580.md) | [95.1](/filings/0001628280-26-050794.md) | [34.5](/filings/0000912766-26-000003.md) | [172 d](/filings/0001628280-26-009479.md) | [(21.6)](/filings/0001628280-26-028580.md) | [137](/filings/0001628280-26-050794.md) | [101](/filings/0000912766-26-000003.md) |
| Diluted EPS | $ per share | not reported | [(0.07)](/filings/0001628280-25-021318.md) | [0.83](/filings/0001628280-25-036830.md) | [0.56](/filings/0001628280-25-047306.md) | not reported | [(0.13)](/filings/0001628280-26-028580.md) | [0.65](/filings/0001628280-26-050794.md) | [0.23](/filings/0000912766-26-000003.md) | not reported | [(0.15)](/filings/0001628280-26-028580.md) | [0.98](/filings/0001628280-26-050794.md) | [0.73](/filings/0000912766-26-000003.md) |
| Basic EPS | $ per share | not reported | [(0.07)](/filings/0001628280-25-021318.md) | [0.83](/filings/0001628280-25-036830.md) | [0.56](/filings/0001628280-25-047306.md) | not reported | [(0.13)](/filings/0001628280-26-028580.md) | [0.65](/filings/0001628280-26-050794.md) | [0.23](/filings/0000912766-26-000003.md) | not reported | [(0.15)](/filings/0001628280-26-028580.md) | [0.98](/filings/0001628280-26-050794.md) | [0.74](/filings/0000912766-26-000003.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [89.4](/filings/0001628280-26-009479.md) | [126](/filings/0001628280-25-021318.md) | [129](/filings/0001628280-25-036830.md) | [134](/filings/0001628280-25-047306.md) | [91.4](/filings/0001628280-26-009479.md) | [110](/filings/0001628280-26-028580.md) | [135](/filings/0001628280-26-050794.md) | [241](/filings/0000912766-26-000003.md) | [147](/filings/0000912766-26-000003.md) | [157](/filings/0001628280-26-028580.md) | [162](/filings/0001628280-26-050794.md) | [190](/filings/0000912766-26-000003.md) |
| Current assets | $m | [224](/filings/0001628280-25-006557.md) | [262](/filings/0001628280-24-019784.md) | [289](/filings/0001628280-24-033877.md) | [261](/filings/0001628280-24-044416.md) | [227](/filings/0001628280-26-009479.md) | [228](/filings/0001628280-25-021318.md) | [323](/filings/0001628280-25-036830.md) | [370](/filings/0001628280-25-047306.md) | [318](/filings/0000912766-26-000003.md) | [271](/filings/0001628280-26-028580.md) | [365](/filings/0001628280-26-050794.md) | [347](/filings/0000912766-26-000003.md) |
| Total assets | $m | [2,126](/filings/0001628280-25-006557.md) | [2,176](/filings/0001628280-24-019784.md) | [2,062](/filings/0001628280-24-033877.md) | [1,927](/filings/0001628280-24-044416.md) | [1,862](/filings/0001628280-26-009479.md) | [1,858](/filings/0001628280-25-021318.md) | [2,036](/filings/0001628280-25-036830.md) | [2,117](/filings/0001628280-25-047306.md) | [2,206](/filings/0000912766-26-000003.md) | [2,281](/filings/0001628280-26-028580.md) | [2,423](/filings/0001628280-26-050794.md) | [2,478](/filings/0000912766-26-000003.md) |
| Current liabilities | $m | [453](/filings/0001628280-25-006557.md) | [474](/filings/0001628280-24-019784.md) | [382](/filings/0001628280-24-033877.md) | [412](/filings/0001628280-24-044416.md) | [368](/filings/0001628280-26-009479.md) | [396](/filings/0001628280-25-021318.md) | [433](/filings/0001628280-25-036830.md) | [459](/filings/0001628280-25-047306.md) | [473](/filings/0000912766-26-000003.md) | [475](/filings/0001628280-26-028580.md) | [513](/filings/0001628280-26-050794.md) | [489](/filings/0000912766-26-000003.md) |
| Total liabilities | $m | [1,176](/filings/0001628280-25-006557.md) | [1,244](/filings/0001628280-24-019784.md) | [1,145](/filings/0001628280-24-033877.md) | [1,030](/filings/0001628280-24-044416.md) | [904](/filings/0001628280-26-009479.md) | [951](/filings/0001628280-25-021318.md) | [983](/filings/0001628280-25-036830.md) | [997](/filings/0001628280-25-047306.md) | [1,018](/filings/0000912766-26-000003.md) | [1,232](/filings/0001628280-26-028580.md) | [1,282](/filings/0001628280-26-050794.md) | [1,317](/filings/0000912766-26-000003.md) |
| Long-term debt | $m | [112](/filings/0001628280-25-006557.md) | [177](/filings/0001628280-24-019784.md) | [203](/filings/0001628280-24-033877.md) | [130](/filings/0001628280-24-044416.md) | [59.0](/filings/0001628280-26-009479.md) | [91.0](/filings/0001628280-25-021318.md) | [78.1](/filings/0001628280-25-036830.md) | [70.6](/filings/0001628280-25-047306.md) | [73.1](/filings/0000912766-26-000003.md) | [161](/filings/0001628280-26-028580.md) | [165](/filings/0001628280-26-050794.md) | [185](/filings/0000912766-26-000003.md) |
| Shareholders' equity | $m | [950](/filings/0001628280-25-006557.md) | [934](/filings/0001628280-24-019784.md) | [918](/filings/0001628280-24-033877.md) | [898](/filings/0001628280-24-044416.md) | [960](/filings/0001628280-26-009479.md) | [908](/filings/0001628280-25-021318.md) | [1,051](/filings/0001628280-25-036830.md) | [1,119](/filings/0001628280-25-047306.md) | [1,188](/filings/0000912766-26-000003.md) | [1,049](/filings/0001628280-26-028580.md) | [1,141](/filings/0001628280-26-050794.md) | [1,160](/filings/0000912766-26-000003.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [63.4 d](/filings/0001628280-26-009479.md) | [33.2](/filings/0001628280-25-021318.md) | [40.2 d](/filings/0001628280-25-036830.md) | [119 d](/filings/0001628280-25-047306.md) | [40.7 d](/filings/0001628280-26-009479.md) | [57.8](/filings/0001628280-26-028580.md) | [74.1 d](/filings/0001628280-26-050794.md) | [141 d](/filings/0000912766-26-000003.md) | [93.4 d](/filings/0001628280-26-009479.md) | [61.9](/filings/0001628280-26-028580.md) | [111 d](/filings/0001628280-26-050794.md) | [152 d](/filings/0000912766-26-000003.md) |
| Capital expenditure | $m | [29.7 d](/filings/0001628280-26-009479.md) | [15.9](/filings/0001628280-25-021318.md) | [10.7 d](/filings/0001628280-25-036830.md) | [7.9 d](/filings/0001628280-25-047306.md) | [37.3 d](/filings/0001628280-26-009479.md) | [4.6](/filings/0001628280-26-028580.md) | [13.3 d](/filings/0001628280-26-050794.md) | [18.2 d](/filings/0000912766-26-000003.md) | [67.0 d](/filings/0001628280-26-009479.md) | [8.3](/filings/0001628280-26-028580.md) | [27.2 d](/filings/0001628280-26-050794.md) | [27.9 d](/filings/0000912766-26-000003.md) |
| Dividends paid | $m | not reported | [1.6](/filings/0001628280-25-021318.md) | [0.1 d](/filings/0001628280-25-036830.md) | [0.0 d](/filings/0001628280-25-047306.md) | not reported | [0.4](/filings/0001628280-26-028580.md) | [0.1 d](/filings/0001628280-26-050794.md) | [0.0 d](/filings/0000912766-26-000003.md) | not reported | [0.1](/filings/0001628280-26-028580.md) | [0.0 d](/filings/0001628280-26-050794.md) | [0.0 d](/filings/0000912766-26-000003.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-26-009479.md) | [32.9](/filings/0001628280-25-021318.md) | [38.5 d](/filings/0001628280-25-036830.md) | [28.6 d](/filings/0001628280-25-047306.md) | [2.0 d](/filings/0001628280-26-009479.md) | [39.5](/filings/0001628280-26-028580.md) | [32.1 d](/filings/0001628280-26-050794.md) | [0.0 d](/filings/0000912766-26-000003.md) | [144 d](/filings/0001628280-26-009479.md) | [108](/filings/0001628280-26-028580.md) | [77.7 d](/filings/0001628280-26-050794.md) | [73.0 d](/filings/0000912766-26-000003.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [165](/filings/0001628280-23-036192.md) | [157](/filings/0001628280-24-019784.md) | [158](/filings/0001628280-24-033877.md) | [158](/filings/0001628280-24-044416.md) | [157](/filings/0001628280-25-021318.md) | [154](/filings/0001628280-25-036830.md) | [152](/filings/0001628280-25-047306.md) | [148](/filings/0001628280-25-021318.md) | [147](/filings/0001628280-26-050794.md) | [148](/filings/0000912766-26-000003.md) | [140](/filings/0001628280-26-050794.md) | [138](/filings/0000912766-26-000003.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 135,745,894 at 2026-09-30, from the cover of the [10-Q filed 2026-10-29](/filings/0000912766-26-000003.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 07:27 ET. No prices; not investment advice.